Virtual Clinical Trials Challenges and Opportunities: Proceedings of a Workshop (2019) / Chapter Skim
Currently Skimming:
Appendix B: Workshop Speaker Biographical Sketches
Appendix B: Workshop Speaker Biographical Sketches
Pages 87-98
The Chapter Skim interface presents what we've algorithmically identified as the most significant single chunk of text within every page in the chapter.
Select key terms on the right to highlight them within pages of the chapter.
From page 87... ...
She has provided leadership for many programs, including Development and Application of PET and SPECT Imaging Ligands as Biomarkers for Drug Discovery and for Pathophysiological Studies of CNS Disorders, the National Cooperative Drug/Device Discovery/Development Groups for the Treatment of Mental Disorders, and First in Human and Early Stage Clinical Trials of Novel Investigational Drugs or Devices for Psychiatric Disorders.
|
From page 88... ...
He developed AMECHealth.org as the official health information-sharing channel for the African Methodist Episcopal Church (2,000 congregations/ 2 million members)
|
From page 89... ...
He is the founding director of the San Francisco Coordinating Center, an academic research organization, and he has designed and/or conducted several multi- enter, industry-sponsored c pivotal trials of treatments for osteoporosis. He founded 1747, a start-up company that developed and conducted one of the first successful Internetbased clinical trials in 2000.
|
From page 90... ...
of the Data and Research Center of the All of Us Research Program (previously called the Precision Medicine Initiative Cohort Program) , which will eventually enroll at least 1 million Americans in an effort to understand the genetic, environmental, and behavioral factors that influence human health and disease.
|
From page 91... ...
She started her career at Boston Medical Center as a research assistant working on pediatric AIDS and oncology trials. After working in academia, she moved into industry and held various clinical operations positions at Boston-area biotechnology/ pharmaceutical companies, including Genzyme, Antigenics, and Novelos Therapeutics, where she was the vice president of clinical development.
|
From page 92... ...
for multiple networks and clinical trials, such as the National Heart, Lung, and Blood Institute's Heart Failure Research Network, Patient-Centered Outcomes Research Institute's National Patient-Centered Clinical Research Network, and the National Institutes of Health's Health Care Systems Research Collaboratory. He has served as the Steering Committee Chair or PI of multiple large studies in the field of cardiovascular medicine and diabetes.
|
From page 93... ...
He previously served as venture partner in Pfizer Venture Investments (Pfizer's venture capital arm) , where he focused on diversifying the company's $50 million annual budget for private investments in the areas of diagnostics and health technology.
|
From page 94... ...
Lipset serves on the Board of Directors for the People-Centered Research Foundation, the Foundation for Sarcoidosis Research, and the MedStar Health Research Institute, and is a mentor at health technology accelerator Blueprint Health. Leanne Madre, J.D., M.H.A., advises and supports the executive director in setting and carrying out organizational strategies in support of the Clinical Trials Transformation Initiative's (CTTI's)
|
From page 95... ...
Sally Okun, B.S.N., R.N., M.M.H.S., is vice president for policy and ethics at PatientsLikeMe. Since joining the company in 2008, she has overseen numerous aspects of the site's early development related to health data integrity, medical ontology, drug safety platforms, and more, recently leading the development of the company's Ethics and Compliance Advisory Board.
|
From page 96... ...
She was a 2010 ellow in biomedical informatics for the National Library of Medicine f and a 2014 Salzburg Global Fellow in New Paradigms for Behavioral and Mental Health. Josh Rose, M.B.A., is the vice president and global head of strategy for the R&D Solutions business unit at IQVIA.
|
From page 97... ...
Dr. Weber's interests include the use of complementary medicine interventions for common pediatric conditions, mental health conditions, promoting healthy behaviors, and health services research.
|
From page 98... ...
He has led mission-critical activities, including the publication of high priority, nationally impactful regulations; the publication of the Shared Nationwide Interoperability Roadmap, a widely publicized congressional report on information blocking; and ONC's efforts in the precision medicine initiative.
|
Key Terms
This material may be derived from roughly machine-read images, and so is provided only to facilitate research.
More
information on Chapter Skim is available.